Position in ANIP
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$16,906,076
-$5,309,766 QoQ
Shares Held
219,845
-21.9% QoQ
Ownership
0.967%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in ANIP Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $4,148,480,732 across 73 Drug Manufacturers - Specialty & Generic names. ANIP ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,145,735 | $1,672,167,321 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
409,288 | $242,699,592 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,426,253 | $223,678,734 | |
| 4 | VTRS |
Viatris Inc
|
16,089,939 | $217,375,067 | |
| 5 | HLN |
Haleon plc
|
19,166,253 | $191,854,187 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
8,889,088 | $184,537,462 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
1,219,196 | $160,616,870 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
6,417,527 | $153,571,413 |
All Filings in ANIP
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $16,906,076 | 219,845 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $22,215,842 | 281,427 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $21,253,579 | 232,026 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $13,107,155 | 200,876 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $29,287,474 | 437,453 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,525,228 | 226,578 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $23,943,283 | 401,329 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $17,215,184 | 270,339 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $17,438,729 | 252,260 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $12,789,334 | 231,943 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $12,753,051 | 219,653 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $9,788,068 | 181,833 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,136,477 | 104,141 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,071,755 | 101,212 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,884,339 | 120,857 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,427,891 | 115,534 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $1,300,197 | 46,254 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $1,981,529 | 43,002 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,181,632 | 96,942 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,729,948 | 106,418 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,931,235 | 108,778 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $4,634,956 | 159,606 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,561,115 | 126,236 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $4,508,646 | 139,414 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,017,847 | 24,984 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||